Steep Pulse Ablation Instrument (including Disposable Sterile Steep Pulse Probe) (SPA-C02) +2 more— 510(k) K253846

Substantially Equivalent

Hangzhou Ruidi Biotechnology , Ltd.

FDA 510(k) clearance K253846 for Steep Pulse Ablation Instrument (including Disposable Sterile Steep Pulse Probe) (SPA-C02) +2 more, Substantially Equivalent on 2026-08-12. Applicant: Hangzhou Ruidi Biotechnology , Ltd.. Device class: 2.

Summary

Hangzhou Ruidi Biotechnology's submission lists a Steep Pulse Ablation Instrument (SPA-C02), described as including a disposable sterile probe, plus a Disposable Sterile Steep Pulse Probe (NPA-DJ01) and a probe connection line (NPA-LX-02). The product code is OAB, low energy direct current thermal ablation systems.

Class II, 21 CFR 878.4400. General and Plastic Surgery is both the classification panel and the review panel. It was a Traditional 510(k).

Ruidi filed from Hangzhou, China. The substantially equivalent decision came 253 calendar days after receipt (December 2, 2025 to August 12, 2026).

Clearance details

Device name as filed
Steep Pulse Ablation Instrument (including Disposable Sterile Steep Pulse Probe) (SPA-C02); Disposable Sterile Steep Pulse Probe (NPA-DJ01); Probe connection line (NPA-LX-02)
Applicant
Hangzhou Ruidi Biotechnology , Ltd.
Product code
Product code OAB
Device class
Class 2
Regulation
21 CFR 878.4400
Advisory panel
General, Plastic Surgery
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Hangzhou, CN
Download summary PDFView on FDA.gov ↗

Recent devices under product code OAB

view all

Adverse events under product code OAB

product code OAB
Death
5
Total
5

Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.